Dr. Honrado is pleased to announce that he now offers LATISSE™.
Allergan, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved LATISSE™ 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE™ is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
Available only through a doctor, LATISSE™ is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. LATISSE™ users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE™ is required. If use of LATISSE™ is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).
LATISSE™ will be available in the United States by prescription only.Please contact the office for more details.
Tell your friend/s about our site! Let them know about your experience in visiting our site and how we might be able to help them with their needs through our services.
